Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Diagnostic Centre, University Clinic for Development of Innovative Patient Pathways, Silkeborg Regional Hospital, Silkeborg, Denmark.
BMJ. 2024 Apr 17;385:e077209. doi: 10.1136/bmj-2023-077209.
OBJECTIVES: To examine how the lifetime risks of atrial fibrillation and of complications after atrial fibrillation changed over time. DESIGN: Danish, nationwide, population based cohort study. SETTING: Population of Denmark from 1 January 2000 to 31 December 2022. PARTICIPANTS: 3.5 million individuals (51.7% women and 48.3% men) who did not have atrial fibrillation at 45 years of age or older were followed up until incident atrial fibrillation, migration, death, or end of follow-up, whichever came first. All 362 721 individuals with incident atrial fibrillation (46.4% women and 53.6% men), but with no prevalent complication, were further followed up until incident heart failure, stroke, or myocardial infarction. MAIN OUTCOME MEASURES: Lifetime risk of atrial fibrillation and lifetime risks of complications after atrial fibrillation over two prespecified periods (2000-10 2011-22). RESULTS: The lifetime risk of atrial fibrillation increased from 24.2% in 2000-10 to 30.9% in 2011-22 (difference 6.7% (95% confidence interval 6.5% to 6.8%)). After atrial fibrillation, the most frequent complication was heart failure with a lifetime risk of 42.9% in 2000-10 and 42.1% in 2011-22 (-0.8% (-3.8% to 2.2%)). Individuals with atrial fibrillation lost 14.4 years with no heart failure. The lifetime risks of stroke and of myocardial infarction after atrial fibrillation decreased slightly between the two periods, from 22.4% to 19.9% for stroke (-2.5% (-4.2% to -0.7%)) and from 13.7% to 9.8% for myocardial infarction (-3.9% (-5.3% to -2.4%). No evidence was reported of a differential decrease between men and women. CONCLUSION: Lifetime risk of atrial fibrillation increased over two decades of follow-up. In individuals with atrial fibrillation, about two in five developed heart failure and one in five had a stroke over their remaining lifetime after atrial fibrillation diagnosis, with no or only small improvement over time. Stroke risks and heart failure prevention strategies are needed for people with atrial fibrillation.
目的:研究心房颤动和心房颤动后并发症的终生风险随时间的变化情况。
设计:丹麦全国性基于人群的队列研究。
设置:2000 年 1 月 1 日至 2022 年 12 月 31 日期间丹麦的人群。
参与者:350 万年龄在 45 岁及以上、无心房颤动的个体,随访至发生心房颤动、移民、死亡或随访结束,以先发生者为准。所有 362721 名患有心房颤动(46.4%为女性,53.6%为男性)但无现有并发症的患者进一步随访至发生心力衰竭、中风或心肌梗死。
主要观察指标:两个预设时间段(2000-10 年和 2011-22 年)内心房颤动和心房颤动后并发症的终生风险。
结果:2000-10 年,心房颤动的终生风险为 24.2%,2011-22 年为 30.9%(差异为 6.7%(95%置信区间为 6.5%至 6.8%))。心房颤动后最常见的并发症是心力衰竭,2000-10 年的终生风险为 42.9%,2011-22 年为 42.1%(-0.8%(-3.8%至 2.2%))。患有心房颤动的个体在没有心力衰竭的情况下失去了 14.4 年的生命。两个时期之间,心房颤动后中风和心肌梗死的终生风险略有下降,中风从 22.4%降至 19.9%(-2.5%(-4.2%至 -0.7%)),心肌梗死从 13.7%降至 9.8%(-3.9%(-5.3%至 -2.4%))。没有证据表明男性和女性之间的下降存在差异。
结论:在 20 多年的随访中,心房颤动的终生风险增加。在患有心房颤动的个体中,约五分之二的人在心房颤动诊断后会发生心力衰竭,五分之一的人会发生中风,而且随着时间的推移,这些风险没有或仅有微小的改善。需要针对患有心房颤动的人制定中风风险和心力衰竭预防策略。
Cochrane Database Syst Rev. 2025-5-6
Cochrane Database Syst Rev. 2021-11-5
Cochrane Database Syst Rev. 2024-9-17
Cochrane Database Syst Rev. 2025-2-10
J Cardiovasc Dev Dis. 2025-5-28
Herzschrittmacherther Elektrophysiol. 2025-6
Nat Rev Cardiol. 2023-9
Eur J Epidemiol. 2022-2